Limitations of non-pharmacological anti-hypertensive therapy
Ozono, R.; Kambe, M.; Oshima, T.; Kajiyama, G.
Nihon Rinsho. Japanese Journal of Clinical Medicine 58(Suppl 2): 73-77
2000
ISSN/ISBN: 0047-1852 PMID: 11028297 Document Number: 524151
Document emailed within 1 workday
Related Documents
Materson, B.J.; Reda, D.J.; Cushman, W.C.; Henderson, W.G. 1995: Results of combination anti-hypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents Journal of human hypertension 9(10): 791-796Costa, F.V.; Ambrosioni, E.; Piovaccari, G.; Magnani, B. 1979: Usefulness of self-measurement of arterial pressure in the control of anti-hypertensive therapy Giornale di Clinica Medica 60(6): 490-499
Wang, J-guang.; Huang, Q-fang. 2007: Blood pressure control and optimization of benefit from anti-hypertensive therapy Zhonghua Nei Ke Za Zhi 46(8): 617-618
Amira, C.O.; Okubadejo, N.U. 2007: Factors influencing non-compliance with anti-hypertensive drug therapy in Nigerians Nigerian Postgraduate Medical Journal 14(4): 325-329
Rossi, E.; Cavatorta, A.; Arisi, L.; Bignardi, L.; David, S.; Garini, G.; Savazzi, G.; Airoldi, G.; Scotti, A.; Cambi, V. 1986: Anti-hypertensive therapy with acebutolol in patients under hemodialysis treatment. 12-month follow-up Minerva Urologica e Nefrologica 38(4): 449-459
Sau, F.; Seguro, C.; Pisano, M.R.; Pirisi, R.; Raffo, M.; Cherchi, A. 1982: Effect of the anti-hypertensive therapy with atenolol on the dimensions and function of the left ventricle Cardiologia 27(2): 173-181
Fager, G.; Berglund, G.; Bondjers, G.; Elmfeldt, D.; Lager, I.; Olofsson, S.O.; Smith, U.; Wiklund, O. 1983: Effects of anti-hypertensive therapy on serum lipoproteins. Treatment with metoprolol, propranolol and hydrochlorothiazide Artery 11(4): 283-296
Yanagawa, Y.; Ogura, M.; Okuda, E.; Okunaga, T.; Takahata, H.; Nakamura, M. 2003: A case of moyamoya disease diagnosed by cerebral ischemic symptoms induced by anti-hypertensive therapy No Shinkei Geka. Neurological Surgery 31(3): 275-279
Buranakitjaroen, P.; Phoojaroenchanachai, M.; Thongma, P.; Wimonsophonkitti, R. 2016: Effect of Anti-Hypertensive Medication Withdrawal in Well-Controlled Treated Hypertensive Patients: Preliminary Results Journal of the Medical Association of Thailand 99(2): 133-141
Baldrighi, V.; Baldrighi, G.; Ronzoni, L.; Aiazzi, L.; Caprioli, G. 1977: Comparative human studies of a new anti-hypertensive drug (2,6-dichloro-benzylidene-aminoguanidine acetate) and methyldopa in hypertensive patients Archivio Per le Scienze Mediche 134(2): 185-192
Nakamura, H.; Kadokawa, T.; Nakatsuji, K.; Nakamura, K. 1970: Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity Arzneimittel-Forschung 20(8): 1032-1046
Tamura, K.; Yutoh, J.; Matsushita, K.; Sakai, M.; Oshikawa, J. 2015: Hypertension with chronic kidney disease: anti-hypertensive therapy recommended for the management of hypertension with CKD in JSN-CKD GL 2013 and JSH2014 Nihon Rinsho. Japanese Journal of Clinical Medicine 73(11): 1876-1884
Ahmad, M.; MahayRookh, -; Rehman, A.B.; Muhammad, N.; Amber, -; Younus, M.; Wazir, A. 2014: Assessment of anti-inflammatory, anti-ulcer and neuro-pharmacological activities of Cyperus rotundus Linn Pakistan Journal of Pharmaceutical Sciences 27(6 Spec No.): 2241-2246
Fiumicelli, A.; Bruni, L. 1986: Indications, possibilities and limitations of the radiological examination in hypertensive patients La Clinica Terapeutica 116(4): 323-334
Wu, P-Sheng. 2010: Combined anti-hypertensive and anti-atherosclerosis treatment for patients with high blood pressure. Zhonghua Nei Ke Za Zhi 49(2): 102
Markiewicz, M.; Florkiewicz, H.; Staśkiewicz, J. 1979: Effect of pharmacological treatment withdrawal on the blood pressure in hypertensive patients Polski Tygodnik Lekarski 34(11): 423-424
Perosa, F.; Scudeletti, M.; Imro, M.A.; Dammacco, F.; Luccarelli, G.; Indiveri, F. 1997: Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases Clinical and Experimental Rheumatology 15(2): 201-210
Cottin, S.; Ponge, A.; Ponge, T.; Fruneau, P. 1989: Limitations of normal eosinophilia or possible influence of nonsteroidal anti-inflammatory agents Therapie 44(4): 297-299
Puygauthier-Toubas, D.; Pailler, S.; Marx-Chemla, C.; Léon, A.; Pignon, B.; Bonnin, A.; Spehner, V.; Pinon, J.M. 1991: Value and limitations of anti-mannan antibodies research by co-immunoelectrodiffusion in the diagnosis of deep candidiasis Pathologie-Biologie 39(3): 200-204
Cavero, I.; Lorrain, J.; Di Paola, E.D.; Lhoste, F.; Payen, B.; Dennis, T.; Scatton, B. 1985: Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs Journal of Pharmacology and Experimental Therapeutics 235(3): 798-809